Corvus Pharmaceuticals | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (30)

View All

Latest Posts

About This Stock More About This Stock
Biotech Alert: Searches Spiking For These Stocks Today - Friday, June 2
Article By: The Fly
Friday, June 2, 2023 4:30 PM EDT
Various names in the biotech sector are seeing a substantial increase in search activity today. Such names include the likes of Akebia Therapeautics, Corvus Pharmaceuticals, and Mirati Therapeutics.
In this article: CHRS, AKBA, CRVS, IOVA, MRTX
Read
Corvus Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, March 8, 2018 9:20 PM EDT
Corvus Pharmaceuticals, Inc. today announced the pricing of an underwritten public offering of 7,058,824 shares of its common stock at a price to the public of $8.50 per share.
In this article: CRVS
Read
Staying Cautious On Corvus Pharma IPO
Article By: Don Dion
Wednesday, March 23, 2016 12:28 PM EDT
Based in Burlingame, California, CRVS is a clinical stage biopharmaceutical company, focused on immune-based cancer treatments. We suggest holding off, particularly given the sluggish IPO market.
In this article: CRVS
Read
Corvus Announces Pricing Of Initial Public Offering
Article By: NASDAQ GlobeNewswire
Wednesday, March 23, 2016 4:13 AM EDT
Corvus Pharmaceuticals will IPO on Wednesday March 23; offering price for 4.7 million shares is $15.
In this article: CRVS
Read
All Posts

Latest Tweets for $CRVS

No tweets yet!

PARTNER HEADLINES

$CRVS

Comments Status Updates
Biotech Alert: Searches Spiking For These Stocks Today - Friday, June 2
Andrew Armstrong • 6/4/2023 3:31:55 PM

$CHRS $MRTX $AKBA $CRVS $IOVA Crvs should be running starting Monday One on one meeting with Richard Miller and Jeffries Co on June 7 Then Lugano on June 17th.

1 to 1 of 1 comments